Microsoft told carbon-removal project developers it is shelving contracts under negotiation; Microsoft has been a major backer of carbon capture tech (Alastair Marsh/Bloomberg)April 23, 2026
Alnylam amyloidosis drug led to “small” benefits: FDA Markets September 11, 2023 Grandbrothers The U.S. Meals and Drug Administration (FDA) mentioned Monday that patisiran, a RNAi therapeutic developed by Alnylam Prescribed drugs…
